What Breaking Bad teaches you about smart-beta funds

Matthew Partridge looks at what lessons television drama Breaking Bad holds for investors.

0926-Bryan-Cranston-634

Bryan Cranston from Breaking Bad
(Image credit: 2018 Getty Images)

Breaking Bad is a TV series that ran for five series from January 2008 to September 2013. It charts the life of Walter White, a mild-mannered chemistry teacher whose world is turned upside down when he is diagnosed with lung cancer.

In an effort to cover the cost of treatment and secure his family's financial future, he joins forces with former pupil and small-time drug dealer Jesse Pinkman to manufacture methamphetamine. Over time, White becomes a ruthless drug lord, teaming up with drug cartels to expand his market.

The key moment

Early on, White attempts to make meth for the first time in a camper van he has bought for the purpose. Initially, Pinkman scoffs at his partner's insistence on using proper procedures, with precise measurements and proper equipment, favouring a more "artistic" approach.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

At the insistence of his former teacher, Pinkman reluctantly follows the instructions. When he samples the final product, Pinkman is amazed at its quality and exclaims "This is this is art, Mr White!" "Actually, it's just basic chemistry," White retorts.

Lessons for investors

Just like White, some in the fund-management industry aim to apply basic science to improve its products. Their "smart-beta" funds aim to beat the market, just as active fund managers do.

However, they eschew the art of stockpicking in favour of a scientific approach that combines the low cost of passively tracking stock indices with stock-picking strategies that have been shown in academic studies consistently to beat the market, such as value investing. Because smart-beta funds automatically follow set criteria, they eliminate the need for a human manager. This should keep fees low and eliminate human biases.

There are three types of smart-beta fund. One group aims to replicate a market index, but in a slightly different way from the traditional method of weighting by market capitalisation. For instance, they might allocate shares in their portfolio according to earnings or dividends.

A more "active" group only buys stocks that perform best against certain criteria. Some funds go further by screening and ranking stocks by multiple criteria. However, the more elaborate the approach, the higher the fees, and the lower the cost advantage. Whether such strategies will make investors as stinking rich as Walter White became remains to be seen.

Dr Matthew Partridge
Shares editor, MoneyWeek

Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.

He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.

Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.

As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.

Follow Matthew on Twitter: @DrMatthewPartri